Research Article

Hepatitis B Virus Reactivation Potential Risk Factors in Hepatocellular Carcinoma via Transcatheter Arterial Chemoembolization: A Retrospective Research

Table 1

T cell changes in patients before and after TACE.

T cell subgroupsPre-TACEPost-TACEt value value

CD3+ (%)55.36 ± 8.7650.65 ± 5.974.718<0.001
CD4+ (%)26.79 ± 4.3122.77 ± 3.637.335<0.001
CD4+/CD8+0.95 ± 0.130.83 ± 0.175.828<0.001